<div id="readability-page-1"><div><p>Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2025. These A-Shares will be under lockup for 2193 days starting from 24-SEP-2019 to 25-SEP-2025.</p><p>  Details:<br/> The Company's holding shareholder Guangdong Guanghui Investment Co., Ltd., actual controllers Lin Peiqing and Chen Qiong, and shareholders Gao Feng, Lin Peichun, Lin Qixiong, and Lin Peina have agreed not to dispose of their interest for a period of 36 months from the date of listing.</p><p>  The Company's shareholders Shantou Zhengnuo Investment Management Partnership Enterprise (Limited Partnership), Yao Zhuangmin, and Yang Rui have agreed not to dispose of their interest for a period of 12 months from the date of listing.</p><p>After the expiry of the lock-up period, the parties promise that yearly transfer of shares made by them will not exceed 25% of the holding, both direct and indirect, held by the present parties.</p></div></div>

仙樂健康

<p>某些仙樂健康的 A 股在鎖定協議下，直到 2025 年 9 月 25 日，鎖定期為 2193 天，自 2019 年 9 月 24 日起計算。主要股東，包括廣東廣匯投資有限公司等，承諾在上市後 36 個月內不處置其股份，而部分股東則有 12 個月的限制。鎖定期結束後，年度股份轉讓將限制在其持股的 25% 以內</p>

仙樂健康有限公司的部分 A 股受到鎖定協議的限制，該協議將於2025年9月25日到期